PPT-206: Engaging Families Experiencing Opioid Use, Addiction, and Recovery

Author : yoshiko-marsland | Published Date : 2018-09-25

Section I welcome and introductions 2 Name Tent 3 Years of service Experience with families experiencing opioid use or addiction Personal goal for this training

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "206: Engaging Families Experiencing Opi..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

206: Engaging Families Experiencing Opioid Use, Addiction, and Recovery: Transcript


Section I welcome and introductions 2 Name Tent 3 Years of service Experience with families experiencing opioid use or addiction Personal goal for this training NAME County Learning Objectives. Bob Sammons, M.D., Ph.D.. Mesa Behavioral Medicine Clinic. TMS Solutions. Conflict of interest. None.      Dr. Sammons received a bachelors and master’s degree from Auburn University, a PhD in clinical psychology from the University of North Carolina at Greensboro, and a medical degree from the University of North Carolina at Chapel Hill.  He did a residency in psychiatry at the University of Virginia as well as a forensic fellowship.  While serving in the United States Air Force as a squad commander and captain, he was selected as one of 5 psychologist to establish the opiate treatment phase of the drug treatment program for the Department of Air Force in 1972.  For this he receive the  Meritorious Service Medal.  He has practiced adult psychiatry in Grand Junction for 28 years.  He is 1 of 2 physicians in town that have received specialist training and a special DEA number that allows him to prescribe Suboxone treatment for opiate dependency.. Fighting the Stigma. Jeffrey Quamme . Executive Director, Connecticut Certification Board. 2018 UVU Conference. Orem, Utah. Our Goals For Today. Understand the history of MAT for Opioid Use Disorders. . Learning Objectives:. Identify the impact of opioid use, addiction, and recovery on child development. Identify warning signs of opioid . use and abuse. Discuss the five components of recovery. Improvement Protocol (TIP) 63:. Medications for Opioid Use Disorder . Name of Presenter . Position Title. Substance Abuse and Mental Health Services Administration . U.S. Department of Health and Human Services. Mental Health Roundtable. October 6, 2017. Last year, 1138 . Virginians died . from . an opioid overdose. . Profile of Opioid Addiction. Opioids are natural and synthetic compounds that bind to the brain’s opioid receptors and trigger the release of dopamine. . MAT BASICS Peter Mason MD Medical Director Region 1 IDN Opioid Use Disorder (OUD) Opioid Use Disorder (OUD): A medical condition characterized by a problematic pattern of opioid use that causes clinically significant impairment or distress. The Treatment and Recovery Continuum in the Age of Opioids Yngvild Olsen, MD, MPH Medical Consultant Maryland Behavioral Health Administration May 16, 2019 LEARNING OBJECTIVES Describe the current status of the overdose and addiction crisis in Maryland Nick Szubiak, MSW, LCSW. Director, Clinical Excellence in Addictions. National Council for Behavioral Health. Objectives. Understand why and how Medication Assisted Treatment works and why we don't use it by challenging the way we view, judge and think about addiction.. Jaye M Shyken, MD. St Louis University School of Medicine. Oct 3, 2018. I Have No Financial Conflict of Interest to Report. 2017 Opioid Addiction in the US. In 2016, 11.8 million Americans age 12 or older misused opioids (4.4%). . . Andrew Kolodny, M.D.. Chief Medical Officer. Phoenix House Foundation. New York, NY. The Opium Poppy. Papaver Somniferum. 2. Crude Opium Latex on Poppy Head. 3. Opioids. Morphine . Codeine. Thebaine. For Providers and Primary Care Teams. Medication Treatment for Opioid . U. se . D. isorder. Developer: . Joe Merrill, MD, University of . Washington,. Charles Morgan MD, and Anne . Griepp. MD, Western New York Collaborative. Stephanie Foster. Weinshenker Lab. Rollins Program in SUD Talk. 12.10.19. Basic science approach to addiction research. Characterize 1) changes that drugs induce in the brain and 2) factors that may increase susceptibility. Community Justice & Safety Symposium. March 3, 2020. Mae Katt, Nurse Practitioner. Outline. Topic: Opioid Addiction. Mae Katt, NP. Dr Claudette Chase. Edna . Quequish. Swanson . Kenequanash. . Questions & Discussion. Knox County . CON Application No. CN2401-002. Cedar Recovery of Middle Tennessee, LLC. Local company founded in 2015 and headquartered in Mt. Juliet.. Owns and operates 13 outpatient addiction treatment clinics in Tennessee and Virginia (“OBOTs” for Office Based Opioid Treatment), including 2 in Knoxville..

Download Document

Here is the link to download the presentation.
"206: Engaging Families Experiencing Opioid Use, Addiction, and Recovery"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents